Nightingale Health Oyj (OTCPK:NGHL.F) - Stock Price, News & Analysis

NGHL.F Stock Overview

A health technology company, offers health data platform that detects disease risks.

NGHL.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 28% below our estimate of its fair value

Revenue is forecast to grow 52.43% per year

Risk Analysis

Shares are highly illiquid

Currently unprofitable and not forecast to become profitable over the next 3 years

Does not have meaningful revenue (€4M)

Nightingale Health Oyj Competitors

Viemed Healthcare

NasdaqCM:VMD

US$285.4m

Accolade

NasdaqGS:ACCD

US$312.8m

Talkspace

NasdaqCM:TALK

US$304.5m

AirSculpt Technologies

NasdaqGM:AIRS

US$214.2m

Price History & Performance

Summary of all time highs, changes and price drops for Nightingale Health Oyj
Historical stock prices
Current Share Price	€1.75
52 Week High	€1.75
52 Week Low	€1.75
Beta	0.70
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	NGHL.F	US Healthcare	US Market
7D	0%	-0.7%	1.6%
1Y	n/a	14.9%	22.0%

Return vs Industry: Insufficient data to determine how NGHL.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how NGHL.F performed against the US Market.

Price Volatility

Is NGHL.F's price volatile compared to industry and market?
NGHL.F volatility
NGHL.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: NGHL.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NGHL.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2002	81	Teemu Suna	nightingalehealth.com

Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company’s blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare industry and researchers in Finland, the United Kingdom, rest of Europe, and internationally.

Nightingale Health Oyj Fundamentals Summary

How do Nightingale Health Oyj's earnings and revenue compare to its market cap?
NGHL.F fundamental statistics
Market cap	US$266.15m
Earnings (TTM)	-US$19.96m
Revenue (TTM)	US$4.04m

65.9x

P/S Ratio

-13.3x

P/E Ratio

Is NGHL.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NGHL.F income statement (TTM)
Revenue	€3.65m
Cost of Revenue	€884.00k
Gross Profit	€2.77m
Other Expenses	€20.83m
Earnings	-€18.06m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 20, 2024

Earnings per share (EPS)	-0.30
Gross Margin	75.81%
Net Profit Margin	-494.23%
Debt/Equity Ratio	1.7%

How did NGHL.F perform over the long term?

See historical performance and comparison

Nightingale Health Oyj OTCPK:NGHL.F Stock Report